Abstract
Progressive left ventricular (LV) dysfunction is a characteristic feature of the failing heart. The mechanism or mechanisms that drive this progression are not known. In recent years, we advanced a working hypothesis that progressive LV dysfunction in heart failure results, in part, from ongoing loss of cardiomyocytes. More recently evidence emerge based on studies in animals with heart failure and in explanted failed human hearts that ongoing cardiomyocyte death through apoptosis occurs in heart failure, a finding that supports the original hypothesis. While these findings created considerable enthusiasm, some skepticism remains even today as to whether cardiomyocyte apoptosis plays an important role in the progression of heart failure. The evidence garnered over the past few years, when considered in aggregate, does favors apoptosis as a key culprit in the progression of the heart failure. Nonetheless, additional key studies are needed to determine if direct inhibition of apoptosis with specific pharmacologic probes prevents progressive LV dysfunction in heart failure. Only then can one fully appreciate the importance of cardiomyocyte apoptosis in the pathophysiology of heart failure.
Similar content being viewed by others
References
Sabbah HN, Sharov VG, Riddle JM, Kono T, Lesch M, Goldstein S. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1992; 24: 1333-1347.
Sharov VG, Sabbah HN, Shimoyama H, et al. Abnormalities of contractile structures in viable myocytes of the failing heart. Intl J Cardiol 1994; 43: 287-297.
Sabbah HN, Sharov VG, Lesch M, Goldstein S. Progression of heart failure: A role for interstitial fibrosis. Mol Cell Biochem 1995; 147: 29-34.
Perennec J, Hatt PY. Myocardial morphology in cardiac hypertrophy and failure: Electron microscopy in man. In: Swynghedauw B, ed. Cardiac Hypertrophy and Failure. London: John Libbey Eurotext, 1988: 267-276.
Sabbah HN, Sharov VG, Goussev A, et al. Evidence for ongoing loss of cardiomyocytes in dogs with progressive left ventricular dysfunction and failure. Circulation 1997; 96: I-754.
Sharov VG, Sabbah HN, Shimoyama H, Goussev A, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996; 148: 141-149.
Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl JMed 1996; 335: 1182-1189.
Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1996; 336: 1131-1141.
Kerr JFR, Wylle AH, Curie AR. Apoptosis: A basic biological phenomenon with widespread implication in tissue kinetics. Br J Cancer 1972; 26: 239-257.
Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-1449.
Savill J. Apoptosis in disease. Europ J Clin Invest 1994; 24: 715-723.
Barr PJ, Tomei LD. Apoptosis and its role in human disease. Bio/Technology 1994; 12: 487-493.
Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990; 67: 871-885.
Sabbah HN, Sharov VG. Apoptosis in heart failure. Prog Cardiovasc Dis 1998; 40: 549-562.
Goldman B, Fisher CA, Johnston E, et al. Caspase-3 expression in failing human hearts. Circulation 1998; 98: I-75.
Sabbah HN, Gupta RC, Singh V, Sharov VG, Mishra S, Goldstein S. Chronic therapy with metoprolol is associated with reduced expression of caspase 3 in left ventricular myocardium of dogs with moderate heart failure. Circulation 1999; 100: I-202.
Todor A, Sharov VG, Gupta RC, et al. DNA fragmentation factor DFF45/ICAD is up-regulated in cardiomyocytes isolated from explanted failed human hearts. J Heart Failure 2000; 6: 63.
Sabbah HN, Sharov VG, Todor A, Singh V, Gupta RC, Goldstein S. Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. J Am Coll Cardiol 2000; 36: 1698-1705.
Goldstein P. Controlling cell death. Science 1997; 275: 1081-1082.
Bialik S, Cryns V, Drincic A, Srinivasan A, Kitsis RN. Cytochrome c release from the mitochondria precedes caspase activation in apoptotic myocytes during ischemia (Abstract). Circulation 1998; 98: I-462.
Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 1996; 12: 2251-2257.
Sharov VG, Goussev A, Lesch M, Goldstein S, Sabbah HN. Abnormal motochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1998; 30: 1757-1762.
Sharov VG, Goussev A, Higgins RSD, et al. Higher incidence of cardiocyte apoptosis in failed explanted hearts of patients with ischemic versus idiopathic dilated cardiomyopathy. Circulation 1997; 96: I-17.
Sabbah HN. Apoptotic cell death in heart failure. Cardiovasc Res 2000; 45: 704-712.
Goussev A, Sharov VG, Shimoyama H, et al. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 1998; 275: H626-H631.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabbah, H.N. Apoptosis in Heart Failure: A Real Problem?. Cardiovasc Drugs Ther 15, 525–528 (2001). https://doi.org/10.1023/A:1013719821673
Issue Date:
DOI: https://doi.org/10.1023/A:1013719821673